Bay Area InnovatorsCEO Tried AI in Drug Testing–Here’s Why It FailedSavePrintDinkar Sindhu Courtesy of Bay Area InnovatorsSteve IspasReporter11/28/2025|Updated: 11/28/2025In today’s episode, Dinkar Sindhu, CEO of Axis Clinicals, dives into the world of clinical research and the cautious integration of AI in drug development.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.